Healthequity Price to Sales

HQY
 Stock
  

USD 66.81  0.06  0.09%   

Healthequity fundamentals help investors to digest information that contributes to Healthequity's financial success or failures. It also enables traders to predict the movement of Healthequity Stock. The fundamental analysis module provides a way to measure Healthequity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthequity stock. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Refresh
Price to Sales Ratio is likely to rise to 7.39 in 2022.

Healthequity Price to Sales Analysis

Healthequity's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
 2021 2022 (projected)
Receivables65.49 M70.66 M
Inventories193.5 K292.37 K
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current Healthequity Price to Sales

    
  7.43 X  
Most of Healthequity's fundamental indicators, such as Price to Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthequity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Healthequity Price to Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Healthequity is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Price to Sales. Since Healthequity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Healthequity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Healthequity's interrelated accounts and indicators.

Healthequity Price to Sales Historical Pattern

Today, most investors in Healthequity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Healthequity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Healthequity price to sales as a starting point in their analysis.
 Healthequity Price to Sales 
Share
      Timeline 
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

Healthequity Price to Sales Ratio

Price to Sales Ratio

7.39

Share
Healthequity Price to Sales Ratio is fairly stable at the moment as compared to the past year. Healthequity reported Price to Sales Ratio of 5.87 in 2021
Based on the latest financial disclosure, the price to sales indicator of Healthequity is roughly 7.43 times. This is 65.28% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The price to sales for all United States stocks is 34.94% higher than that of the company.

Healthequity Price to Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthequity's direct or indirect competition against its Price to Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthequity could also be used in its relative valuation, which is a method of valuing Healthequity by comparing valuation metrics of similar companies.
Healthequity is currently under evaluation in price to sales category among related companies.

Healthequity Current Valuation Drivers

We derive many important indicators used in calculating different scores of Healthequity from analyzing Healthequity's financial statements. These drivers represent accounts that assess Healthequity's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Healthequity's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee46.12 K64.77 K13.53 K2.9 K2.61 K2.68 K
Revenue Per Employee223.49 K251.75 K181.51 K240.73 K216.65 K201.18 K
Average Assets339.77 M465.09 M1.7 B2.65 B3.13 B3.38 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings Before Interest Taxes and Depreciation Amortization USD68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings before Tax52.19 M75.82 M43.16 M4.14 M(66.74 M)(68.5 M)
Average Equity321.87 M440.87 M898.6 M1.28 B1.86 B2.01 B
Enterprise Value2.89 B3.6 B5.82 B7.22 B4.83 B4.65 B
Free Cash Flow65.86 M99.58 M72.07 M117.03 M69.38 M65.61 M
Invested Capital60.91 M35.17 M1.41 B1.16 B1.12 B1.21 B
Invested Capital Average65.25 M73.75 M804.95 M1.26 B1.14 B1.23 B
Market Capitalization3.07 B3.89 B4.68 B6.43 B4.47 B4.35 B
Tangible Asset Value280.87 M425.7 M449.07 M616.21 M488.13 M418.34 M
Working Capital244.91 M365.62 M145.36 M255.48 M198.15 M200.56 M

Healthequity Fundamentals

About Healthequity Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Healthequity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthequity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthequity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Price to Sales Ratio 5.87  7.39 
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Healthequity Investors Sentiment

The influence of Healthequity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Healthequity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Healthequity Implied Volatility

    
  38.11  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Healthequity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Healthequity's short interest history, or implied volatility extrapolated from Healthequity options trading.

Current Sentiment - HQY

Healthequity Investor Sentiment

Greater number of Macroaxis users are currently bullish on Healthequity. What is your judgment towards investing in Healthequity? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Healthequity Piotroski F Score and Healthequity Altman Z Score analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.6 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.